Log in to save to my catalogue

Optimized 68Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer

Optimized 68Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_95ecb855e41d4cd8974b50f50c733252

Optimized 68Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer

About this item

Full title

Optimized 68Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer

Publisher

Basel: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2022-08, Vol.15 (8), p.1001

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals have become some of the most promising tools for the diagnosis and therapy prostate cancer (PCa). The structure of existing PSMA-targeted PET tracers still needs to be optimized to improve their pharmacokinetic properties and tumor-to-background ratio. In this study, we modifi...

Alternative Titles

Full title

Optimized 68Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_95ecb855e41d4cd8974b50f50c733252

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_95ecb855e41d4cd8974b50f50c733252

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph15081001

How to access this item